{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:35:06Z","timestamp":1762353306334,"version":"3.37.3"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801582"],"award-info":[{"award-number":["81801582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Medical Discipline of Shanghai Jiading District","award":["2020-jdyxzdxk-13"],"award-info":[{"award-number":["2020-jdyxzdxk-13"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The aim of this study was to investigate the serum levels of CA242 in different types of gynecological diseases and its clinical significance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 1021 patients with gynecological diseases and 499 healthy female controls were included in the study. The serum CA242 levels were detected and median value, \u2212log10P value, and positive rate were calculated. Serum CA125 and HE4 levels of patients with ovarian lesions were measured, and the predictive value for ovarian cancer was statistically analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Higher serum CA242 levels were observed in patients with mature teratoma, ovarian cancer, and other gynecological tumor diseases than in healthy controls. In contrast, the CA242 levels in patients with cervical intraepithelial neoplasia, uterine polyps, or endometrial hyperplasia were comparable to that of controls. Moreover, serum CA242 expression was increased in malignant uterine and ovarian diseases compared with benign ones (P\u00a0&amp;lt;\u00a0.05). Specifically, combining CA242, CA125, and HE4 yielded a higher area under the receiver operating characteristic curve than single biomarkers (P\u00a0&amp;lt;\u00a0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Heterogeneous increases in tumor marker CA242 expression levels are observed in different gynecological diseases, suggesting its potential value for clinical diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmad017","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T08:08:37Z","timestamp":1681114117000},"page":"613-617","source":"Crossref","is-referenced-by-count":2,"title":["Serum expression of tumor marker CA242 in patients with different gynecological diseases"],"prefix":"10.1093","volume":"54","author":[{"given":"Jing","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Jiading Branch of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huidan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai General Hospital , Shanghai , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"issue":"1","key":"2023110721214590100_CIT0001","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12957-022-02785-x","article-title":"Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer","volume":"20","author":"Su","year":"2022","journal-title":"World J Surg Oncol."},{"issue":"12","key":"2023110721214590100_CIT0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018175","article-title":"Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy","volume":"7","author":"Ge","year":"2017","journal-title":"BMJ Open."},{"issue":"6","key":"2023110721214590100_CIT0003","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3748\/wjg.v27.i6.501","article-title":"Validation of serum tumor biomarkers in predicting advanced cystic mucinous neoplasm of the pancreas","volume":"27","author":"Sun","year":"2021","journal-title":"World J Gastroenterol."},{"issue":"1","key":"2023110721214590100_CIT0004","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3892\/ol.2020.11633","article-title":"Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer","volume":"20","author":"Luo","year":"2020","journal-title":"Oncol Lett."},{"key":"2023110721214590100_CIT0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.pmbts.2018.12.007","article-title":"CA242 as a biomarker for pancreatic cancer and other diseases","volume":"162","author":"Dou","year":"2019","journal-title":"Prog Mol Biol Transl Sci."},{"issue":"1","key":"2023110721214590100_CIT0006","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1724600820981972","article-title":"Circulating tumor cells: a surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma","volume":"36","author":"Zhu","year":"2021","journal-title":"Int J Biol Markers"},{"issue":"14","key":"2023110721214590100_CIT0007","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","article-title":"Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2023110721214590100_CIT0008","doi-asserted-by":"crossref","first-page":"1533033820946423","DOI":"10.1177\/1533033820946423","article-title":"Retrospective study of the epidemiology, pathology, and therapeutic management in patients with mucinous ovarian tumors","volume":"19","author":"Zhang","year":"2020","journal-title":"Technol Cancer Res Treat."},{"issue":"2","key":"2023110721214590100_CIT0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10238-013-0234-9","article-title":"CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis","volume":"14","author":"Gui","year":"2014","journal-title":"Clin Exp Med."},{"issue":"9","key":"2023110721214590100_CIT0010","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1111\/cas.13712","article-title":"Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer","volume":"109","author":"Dong","year":"2018","journal-title":"Cancer Sci."},{"issue":"7","key":"2023110721214590100_CIT0011","first-page":"11683","article-title":"Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"2023110721214590100_CIT0012","first-page":"3541403","article-title":"Expression levels and clinical significance of serum miR-497, CEA, CA24-2, and HBsAg in patients with colorectal cancer","volume":"2022","author":"Liu","year":"2022","journal-title":"Biomed Res Int."},{"issue":"6","key":"2023110721214590100_CIT0013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11306-019-1550-1","article-title":"Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer","volume":"15","author":"Tao","year":"2019","journal-title":"Metabolomics."},{"issue":"2","key":"2023110721214590100_CIT0014","first-page":"383","article-title":"Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer","volume":"31","author":"Lei","year":"2017","journal-title":"J Biol Regul Homeost Agents."},{"issue":"15","key":"2023110721214590100_CIT0015","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.7314\/APJCP.2015.16.15.6569","article-title":"Applicative value of serum CA19-9, CEA, CA125 and CA242 in diagnosis and prognosis for patients with pancreatic cancer treated by concurrent chemoradiotherapy","volume":"16","author":"Gu","year":"2015","journal-title":"Asian Pac J Cancer Prev."},{"issue":"8","key":"2023110721214590100_CIT0016","doi-asserted-by":"crossref","first-page":"e22565","DOI":"10.1002\/jcla.22565","article-title":"Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer","volume":"32","author":"Wang","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"2023110721214590100_CIT0017","first-page":"263","article-title":"Clinical value of combined tests for tumor markers for gastric cancer","volume":"32","author":"Xu","year":"2018","journal-title":"J Biol Regul Homeost Agents."},{"key":"2023110721214590100_CIT0018","doi-asserted-by":"crossref","first-page":"594763","DOI":"10.3389\/fonc.2021.594763","article-title":"Prognostic value of CEA, CA19-9, CA125, CA724, and CA242 in serum and ascites in pseudomyxoma peritonei","volume":"11","author":"Liang","year":"2021","journal-title":"Front Oncol."},{"key":"2023110721214590100_CIT0019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CMAR.S344711","article-title":"Prediction of multiple serum tumor markers in hepatolithiasis complicated with intrahepatic cholangiocarcinoma","volume":"14","author":"Zhao","year":"2022","journal-title":"Cancer Manag Res."},{"issue":"6","key":"2023110721214590100_CIT0020","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1002\/mgg3.672","article-title":"Comprehensive analysis of serum tumor markers and BRCA1\/2 germline mutations in Chinese ovarian cancer patients","volume":"7","author":"Deng","year":"2019","journal-title":"Mol Genet Genomic Med."},{"key":"2023110721214590100_CIT0021","doi-asserted-by":"crossref","first-page":"e13488","DOI":"10.7717\/peerj.13488","article-title":"Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study","volume":"10","author":"Li","year":"2022","journal-title":"PeerJ."},{"issue":"2","key":"2023110721214590100_CIT0022","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.21037\/tcr-20-2434","article-title":"Intralobar pulmonary sequestration with aspergillus infection and elevated serum CA19-9 and CA242: a case report","volume":"10","author":"Ge","year":"2021","journal-title":"Transl Cancer Res."},{"issue":"19","key":"2023110721214590100_CIT0023","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.7314\/APJCP.2014.15.19.8409","article-title":"Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer","volume":"15","author":"Bian","year":"2014","journal-title":"Asian Pac J Cancer Prev."},{"issue":"3","key":"2023110721214590100_CIT0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ijgo.12139","article-title":"Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion","volume":"137","author":"Wang","year":"2017","journal-title":"Int J Gynaecol Obstet."},{"issue":"4","key":"2023110721214590100_CIT0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.12891\/ceog3003.2016","article-title":"The clinical significance of CA19-9 in ovarian mature cystic teratoma","volume":"43","author":"Fan","year":"2016","journal-title":"Clin Exp Obstet Gynecol."},{"key":"2023110721214590100_CIT0026","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/1477-7819-12-353","article-title":"Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary","volume":"12","author":"Suh","year":"2014","journal-title":"World J Surg Oncol."},{"issue":"3","key":"2023110721214590100_CIT0027","doi-asserted-by":"crossref","first-page":"397","DOI":"10.12891\/ceog2128.2016","article-title":"Expression and clinical significance of tumor markers in ovarian mature cystic teratoma","volume":"43","author":"Chen","year":"2016","journal-title":"Clin Exp Obstet Gynecol."},{"issue":"9","key":"2023110721214590100_CIT0028","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0040-1712993","article-title":"Preoperative differentiation of benign and malignant non-epithelial ovarian tumors: clinical features and tumor markers","volume":"42","author":"Gomes","year":"2020","journal-title":"Rev Bras Ginecol Obstet."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/6\/613\/52799278\/lmad017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/54\/6\/613\/52799278\/lmad017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T21:22:13Z","timestamp":1699392133000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/54\/6\/613\/7111498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,4,10]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmad017","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"type":"print","value":"0007-5027"},{"type":"electronic","value":"1943-7730"}],"subject":[],"published-other":{"date-parts":[[2023,11,1]]},"published":{"date-parts":[[2023,4,10]]}}}